Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-11-09

Clinical Trial Update: Subcutaneous Ketamine for Postoperative Pain Relief in Rwanda [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update for subcutaneous ketamine aimed at postoperative pain relief has completed Phase 2/Phase 3 with results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: University of Saskatchewan | Conditions: Post Operative Pain, Pain | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2018-11-09